Trilogy Global Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Trilogy Global Advisors's AMGN Position: Q3 2017 in Review
Trilogy Global Advisors sold out of Amgen (AMGN) in Q3 2017, closing a stake of 189,824 shares — an estimated $32.7M sold.
Trilogy Global Advisors first reported a position in AMGN in Q2 2013 and held it in 17 quarters. The position peaked at $85.3M in Q1 2015. 1,605 funds tracked by Wall St. Rank hold AMGN as of Q3 2017.
- Trilogy Global Advisors reported no remaining Amgen position as of Q3 2017 after selling out during the quarter.
- Trilogy Global Advisors sold 189,824 Amgen shares in Q3 2017, an estimated $32.7M.
- Trilogy Global Advisors first reported a position in Amgen in Q2 2013 and held it in 17 quarters.
- Trilogy Global Advisors's Amgen position peaked at $85.3M in Q1 2015.
- 1,605 funds tracked by Wall St. Rank held Amgen as of Q3 2017.
Based on Trilogy Global Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.